 |
 |
 |
|
|
|||
|
|
||||
|
||||
BREASTHEALTH: TG2 In Chemo-Resistant Ovarian Cancer - late stageFrom: Hope Waltman (anonymous@obgyn.net)Sun, 20 Jul 2008 13:36:45 -0500 (CDT)
TG2 Identified As Potential Therapeutic Target In Chemo-Resistant Ovarian Cancer "Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein may also provide a novel therapeutic approach for late-stage ovarian cancer." These findings in the July 15th issue of Cancer Research http://www.medicalnewstoday.com/articles/115244.php Regards, Hope Waltman, Fibroid Forum and WH Forum Moderator http://www.hopeforfibroids.org http://www.doctorsinfoweb.com/doctors.htm UTERINE FIBROIDS INFO: http://www.obgyn.net/fibroid-resource-center/ http://www.obgyn.net/fibroid-resource-center/?page=articles/patient_articles http://forums.obgyn.net/forums/womens-health/
|
|
Return to ![[ Women's Health Forum ]](http://www.obgyn.net/images_women/wh-forum.gif)
Report TECHNICAL Problems ONLY to: webmaster@obgyn.net
Last Updated: Wed Dec 2 06:55:48 2009
Women's Insurance Checklist from Auto Insurance Quote
home | medical professionals | women | industry | forums | international